Welldoc, a provider in the digital health sector, has unveiled its latest expansion by integrating weight management into its digital chronic care platform. The inclusion is intended to fortify the platform’s multi-condition support, which already encompasses conditions like prediabetes, diabetes, hypertension, and heart failure. This will also be complemented with integrated solutions for mental well-being and sleep apnea. Existing customers can immediately avail of the weight management solution, with a broader rollout planned in partnership with two of American healthcare companies in early 2024.
Weight issues are a growing concern in the U.S., with approximately two-thirds of adults grappling with being overweight or obese. These conditions amplify the risk of chronic diseases such as type 2 diabetes, hypertension, heart failure, and sleep apnea. Welldoc’s approach to this issue is comprehensive. With AI-driven, personalized digital coaching, individuals can embark on their weight management journeys, whether initiating lifestyle changes or being prescribed GLP-1 medication. Welldoc’s platform accentuates the connection between individuals and their health data, aiming to make health goals more accessible and achievable. Additionally, the platform has provisions for clinical escalations and offers decision-making support for care teams when necessary.
Catherine Brown, Welldoc’s Vice President of Clinical Services, expressed her enthusiasm about the new addition: “Weight management aligns perfectly with Welldoc’s existing award-winning chronic care platform. For years, we’ve been at the forefront, offering stellar behavioral support centered around nutrition and physical activity. Our new evidence-backed weight management program reflects our commitment to cater to our users’ evolving needs, integrating seamlessly into existing care plans.”
In its mission to enhance care, optimize health, and curtail expenses, Welldoc collaborates with pharmacy benefit managers, health plans, health systems, and employers. Distinctly, while numerous solutions in the market focus on obesity and GLP-1 medication prescriptions, Welldoc embraces a holistic approach. This encompasses a comprehensive guidance system for individuals, helping them make informed decisions about nutrition, activity, and understanding health patterns over time. Backed by its profound expertise in continuous glucose monitoring (CGM) data usage, Welldoc is strategically positioned to enhance outcomes and ensure adherence, especially as the use of both CGM and GLP-1 continues to grow.